Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_assertion type Assertion NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_head.
- NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_assertion description "[Our in�vitro and in�vivo experiments demonstrated that CD133(+) �ABCG2(+) cells exhibited well-known CSC characteristics; thus when circulating they could be used as a prognostic marker for gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_provenance.
- NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_assertion evidence source_evidence_literature NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_provenance.
- NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_assertion SIO_000772 25727099 NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_provenance.
- NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_assertion wasDerivedFrom befree-2016 NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_provenance.
- NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_assertion wasGeneratedBy ECO_0000203 NP1267185.RARQlMTwOrS9DReopMyQjYnJ8cAA_DI9AxcgVswMsy-KY130_provenance.